Effects of Mammalian and Plant Estrogens on Lipoprotein Metabolism and Coronary Heart Disease

  • Janice D. Wagner
  • Li Zhang
  • Kathryn A. Greaves
  • Dawn C. Schwenke
Conference paper
Part of the Serono Symposia USA book series (SERONOSYMP)

Abstract

Coronary heart disease (CHD) is the leading cause of death in both pre- and postmenopausal women in Western societies. Both natural and surgical menopause are associated with increased risk of CHD (1), although estrogen replacement therapy (ERT) reduces the risk of CHD by about 50% in postmenopausal women (2–4) and the amount of atherosclerosis by about 50% in animal models (5–8). Even though there is overwhelming evidence that estrogen monotherapy markedly reduces the risk of CHD in postmenopausal women, the effects of estrogen/progestin regimens on CHD risk are less clear. A progestin is added to the ERT regimen to reduce the risk of endometrial cancer, and this may detract from estrogen’s beneficial effects. For example, numerous observational studies as well as meta-analyses (2,4) have concluded that ERT reduces risk of CHD. Reports from the Nurses Health Study (9) found similar reductions in CHD risk with ERT and combined estrogen/progestin treatment (HRT); however, a report of the first randomized, blinded, secondary prevention trial the Heart and Estrogen/progestin Replacement Study (HERS)—found no significant differences between CHD events in the placebo group compared with a group treated with combined, continuous estrogen/progestin (conjugated equine estrogens (CEE) plus medroxyprogesterone acetate (MPA) (10).

Keywords

Coronary Heart Disease Risk Coronary Heart Disease Event Coronary Artery Atherosclerosis Nomegestrol Acetate Estrogen Monotherapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Godsland IF, Wynn V, Crook D, Miller NE. Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. Am Heart J 1987;114:1467–503.PubMedCrossRefGoogle Scholar
  2. 2.
    Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prevent Med 1991;20:47–63.CrossRefGoogle Scholar
  3. 3.
    Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA 1991;265:1861–67.PubMedCrossRefGoogle Scholar
  4. 4.
    Barrett-Connor E, Grady D. Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health 1998;19:55–72.PubMedCrossRefGoogle Scholar
  5. 5.
    Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, et al. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of adding progesterone. Arteriosclerosis 1990;10: 1051–57.PubMedCrossRefGoogle Scholar
  6. 6.
    Adams MR, Register TC, Golden DL, Wagner JD, Williams JK. Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol 1997;17:217–21.PubMedCrossRefGoogle Scholar
  7. 7.
    Hough JL, Zilversmit DB. Effect of 17-β estradiol on cholesterol content and metabolism in cholesterol-fed rabbits. Arteriosclerosis 1986;6:57–63.PubMedCrossRefGoogle Scholar
  8. 8.
    Haarbo J, Leth-Espensen P, Stender S, Christiansen C. Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J Clin Invest 1991;87:1274–79.PubMedCrossRefGoogle Scholar
  9. 9.
    Grodstein F, Stampfer MJ, Manson JE, Colditz MB, Willett WC, Rosner B, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453–61.PubMedCrossRefGoogle Scholar
  10. 10.
    Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al., for the HERS research group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Jama 1998;280: 605–18.PubMedCrossRefGoogle Scholar
  11. 11.
    Williams JK, Honoré EK, Washburn SA, Clarkson TB. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J Am Coll Cardiol 1994:24:1757–61.PubMedCrossRefGoogle Scholar
  12. 12.
    Wagner JD, Martino MA, Jayo MJ, Anthony MS, Clarkson TB, Cefalu WT. The effects of hormone replacement therapy on carbohydrate metabolism and cardiovascular risk factors in surgically postmenopausal cynomolgus monkeys. Metabolism 1996;45:1254–62.PubMedCrossRefGoogle Scholar
  13. 13.
    Cefalu WT, Wagner JD, Bell-Farrow AD, Wang ZQ, Adams MR, Toffolo G, et al. The effects of hormonal replacement therapy on insulin sensitivity in surgically postmenopausal cynomolgus monkeys (Macaca fascicularis). Am J Obstet Gynecol 1994;171:440–45.PubMedGoogle Scholar
  14. 14.
    The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. JAMA 1995;273:199–208.CrossRefGoogle Scholar
  15. 15.
    Seed M, Crook D. Post-menopausal hormone replacement therapy, coronary heart disease and plasma lipoproteins. Curr Opinions Lipidol 1994;5:48–58.CrossRefGoogle Scholar
  16. 16.
    Espeland MA, Marcovina SM, Miller V, Wood PD, Wasilauskas C, Sherwin R, et al. Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. Circulation 1998;97;979–86.PubMedCrossRefGoogle Scholar
  17. 17.
    Kim CJ, Ryu WS, Kwak JW, Park CT, Ryoo UH. Changes in Lp(a) lipoprotein and lipid levels after cessation of female sex hormone production and estrogen replacement therapy. Arch Intern Med 1996;156:500–4.PubMedCrossRefGoogle Scholar
  18. 18.
    Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991;325:1196–204.PubMedCrossRefGoogle Scholar
  19. 19.
    Kovanen PT, Brown MS, Goldstein JL. Increased binding of low density lipoprotein to liver membranes from rats treated with 17α-ethinyl estradiol. J Biol Chem 1979;254:11367–73.PubMedGoogle Scholar
  20. 20.
    Ma PT, Yamamoto T, Goldstein JL, Brown MS. Increased mRNA for low density lipoprotein receptors in livers of rabbits treated with 17α-ethinyl estradiol. Proc Natl Acad Sci USA 1986;83:792–96.PubMedCrossRefGoogle Scholar
  21. 21.
    Colvin PL, Wagner JD, Adams MR, Sorci-Thomas MG. Sex steroids increase cholesterol 7 alpha-hydroxylase mRNA in nonhuman primates. Metabolism Clin Exp 1998;47:391–95.CrossRefGoogle Scholar
  22. 22.
    Wagner JD, Zhang L, Adams MR. Effects of estrogens on arterial LDL metabolism. In: Forte T, ed. Hormonal, metabolic, and cellular influences on cardiovascular disease in women. Armonk, NY: Futura Publishing Co., 1997:153–74.Google Scholar
  23. 23.
    Everson GT, McKinley C, Kern F, Jr. Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J Clin Invest 1991;87:237–46.PubMedCrossRefGoogle Scholar
  24. 24.
    Parks JS, Wilson MD, Johnson FL, Rudel LL. Fish oil decreases hepatic cholesteryl ester secretion but not apoB secretion in African green monkeys. J Lipid Res 1989;30:1535–44.PubMedGoogle Scholar
  25. 25.
    Campos H, Walsh BW, Judge H, Sacks FM. Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women. J Clin Endocrinol Metab 1997;82:3955–63.PubMedCrossRefGoogle Scholar
  26. 26.
    Manning JM, Campos G, Edwards IJ, Wagner WD, Wagner JD, Adams MR, et al. Effects of hormone replacement modalities on low density lipoprotein composition and distribution in ovariectomized cynomolgus monkeys. Atherosclerosis 1996;121:217–30.PubMedCrossRefGoogle Scholar
  27. 27.
    Wagner JD, Zhang L, Williams JK, Register TC, Ackerman DM, Wiita B, et al. Esterified estrogens with and without methyltestosterone decrease arterial LDL metabolism in cynomolgus monkeys. Arterioscler Thromb Vasc Biol 1996;16:1473–80.PubMedCrossRefGoogle Scholar
  28. 28.
    Wakatsuke A, Ikenoue N, Sagara Y. Estrogen-induced small low-density lipoprotein particles in postmenopausal women. Obstet Gynecol 1998;91:234–40.CrossRefGoogle Scholar
  29. 29.
    Schwenke DC, Carew TE. Initiation of atherosclerotic lesions in cholesterol-fed rabbits. I. Focal increases in arterial LDL concentration precede development of fatty streak lesions. Arteriosclerosis 1989;9:895–907.PubMedCrossRefGoogle Scholar
  30. 30.
    Wagner JD, Schwenke DC. Lipoprotein metabolism in the vessel wall. In: Rubanyi G, ed. Estrogens and the vessel wall. Berkshire, U.K.: Harwood Academic Publishers, 1998:107–20.Google Scholar
  31. 31.
    Wagner JD, St. Clair RW, Schwenke DC, Shively CA, Adams MR, Clarkson TB. Regional differences in arterial low density lipoprotein metabolism in surgically postmenopausal cynomolgus monkeys: effects of estrogen and progesterone therapy. Arterioscler Thromb 1992;12:717–26.PubMedCrossRefGoogle Scholar
  32. 32.
    Schwenke DC. Aging, menopause and free radicals. In: Murphy AA, Parthasarathy S, eds. Seminars in reproductive endocrinology, free radicals in gynecology and obstetrics. Semin Reprod Endocrinol 1998;16:281–308.Google Scholar
  33. 33.
    Clemente C, Caruso MG, Berloco P, Buonsante A, Giannandrea B, DiLeo A. Alpha-tocopherol and beta-carotene serum levels in post-menopausal women treated with transdermal estradiol and oral medroxyprogesterone acetate. Horm Metab Res 1996;28:558–61.PubMedCrossRefGoogle Scholar
  34. 34.
    Mcmanus J, Mceneny J, Thompson W, Young IS. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women. Atherosclerosis 1997;135:73–81.CrossRefGoogle Scholar
  35. 35.
    Nenseter MS, Volden V, Berg T, Drevon CA, Ose L, Tonstad S. Effect of hormone replacement therapy on the susceptibility of low-density lipoprotein to oxidation among postmenopausal hypercholesterolaemic women. Eur J Clin Invest 1996;26:1062–68.PubMedCrossRefGoogle Scholar
  36. 36.
    Wagner JD, Thomas MJ, Williams JK, Zhang L, Greaves KA, Cefalu WT. Insulin sensitivity and cardiovascular risk factors in ovariectomized monkeys with estradiol alone or combined with nomegestrol acetate. J Clin Endocrinol 1998;83: 896–901.CrossRefGoogle Scholar
  37. 37.
    Lindheim SR, Presser SC, Ditkoff EC. A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin. Fertil Steril 1993;60:664–67.PubMedGoogle Scholar
  38. 38.
    Godsland IF, Gangar K, Walton C, et al. Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. Metabolism 1993;42:846–53.PubMedCrossRefGoogle Scholar
  39. 39.
    Wagner JD, Cefalu WT, Anthony MS, Litwak KN, Zhang L, Clarkson TB. Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys. Metabolism Clin Exp 1997;46:698–705.CrossRefGoogle Scholar
  40. 40.
    Manson JE, Rimm EB, Colditz GA, Willett WC, Nathan DM, Arky RA, et al. A prospective study of postmenopausal estrogen therapy and subsequent incidence of non-insulin-dependent diabetes mellitus. Ann Epidemiol 1992;2:665–73.PubMedCrossRefGoogle Scholar
  41. 41.
    Sullivan JM, Vander Zwaag R, Hughes JP, Maddock V, Kroetz FW, Ramanathan KB, et al. Estrogen replacement and coronary artery disease. Arch Intern Med 1990;150:2557–62.PubMedCrossRefGoogle Scholar
  42. 42.
    Grodstein F, Stampfer MJ, Colditz GA, Willett WC, Manson JE, Joffe M, Rosner B, et al. Postmenopausal hormone therapy and mortality. N Engl J Med 1997; 336:1769–75.PubMedCrossRefGoogle Scholar
  43. 43.
    Hughes CL, Cline JM, Williams JK, Anthony MS, Wagner JD, Clarkson TB. Dietary soy phytoestrogens and the health of menopausal women: overview and evidence of cardioprotection from studies in non-human primates. In: Wren BG, ed. Progress in the management of the menopause. New York: Parthenon Publishing, 1997:30–39.Google Scholar
  44. 44.
    Kuiper GGJM, Carlson B, Grandien K, Enmark E, Häggblad J, Nilsson S, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors a and β. Endocrinology 1997;138:863–70.PubMedCrossRefGoogle Scholar
  45. 45.
    Setchell KDR. Naturally occurring non-steroidal estrogens of dietary origin, and discussion. In: McLachlan JA, ed. Estrogens in the environment. II. Influences on development. New York: Elsevier, 1985:69–85.Google Scholar
  46. 46.
    Paech K, Webb P, Kuiper GGJM, Nilsson S, Gustafsson JA, Kushner PJ, et al. Differential ligand activation of estrogen receptors ERa and ERβ at AP 1 sites. Science 1997;277:1508–10.PubMedCrossRefGoogle Scholar
  47. 47.
    Anthony MS, Clarkson TB, Bullock BC, Wagner JD. Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. Arterioscler Thromb Vasc Biol 1997;17:2524–31.PubMedCrossRefGoogle Scholar
  48. 48.
    Honoré EK, Williams JK, Anthony MS, Clarkson TB. Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques. Fertil Steril 1997;67:148–54.PubMedCrossRefGoogle Scholar
  49. 49.
    Foth D, Cline JM. Effects of mammalian and plant estrogens on mammary glands and uteri of macaques. Am J Clin Nutr 1998;68:14135–75.Google Scholar
  50. 50.
    Register TC, Adams MR. Coronary artery and cultured aortic smooth muscle cells express mRNA for both the classical estrogen receptor and the newly described estrogen receptor beta. J Steroid Biochem Mol Biol 1998;64:187–91.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 2000

Authors and Affiliations

  • Janice D. Wagner
  • Li Zhang
  • Kathryn A. Greaves
  • Dawn C. Schwenke

There are no affiliations available

Personalised recommendations